KR102013871B1 - Composition for improving hair growth - Google Patents
Composition for improving hair growth Download PDFInfo
- Publication number
- KR102013871B1 KR102013871B1 KR1020170165200A KR20170165200A KR102013871B1 KR 102013871 B1 KR102013871 B1 KR 102013871B1 KR 1020170165200 A KR1020170165200 A KR 1020170165200A KR 20170165200 A KR20170165200 A KR 20170165200A KR 102013871 B1 KR102013871 B1 KR 102013871B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- hair
- powder
- extract
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract description 41
- 230000012010 growth Effects 0.000 title description 5
- 230000003752 improving hair Effects 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 75
- 239000000843 powder Substances 0.000 claims abstract description 63
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims abstract description 35
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims abstract description 34
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 22
- 210000004761 scalp Anatomy 0.000 claims abstract description 21
- 235000007215 black sesame Nutrition 0.000 claims abstract description 14
- 239000010865 sewage Substances 0.000 claims abstract description 13
- 235000020234 walnut Nutrition 0.000 claims abstract description 13
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 12
- 240000007049 Juglans regia Species 0.000 claims abstract 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 34
- 244000304217 Brassica oleracea var. gongylodes Species 0.000 claims description 24
- 229920002113 octoxynol Polymers 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 8
- 230000035515 penetration Effects 0.000 claims description 8
- 239000008213 purified water Substances 0.000 claims description 8
- 241000199919 Phaeophyceae Species 0.000 claims description 3
- -1 alkyl phenol Chemical compound 0.000 claims 1
- 230000003779 hair growth Effects 0.000 abstract description 31
- 230000001737 promoting effect Effects 0.000 abstract description 16
- 241001474374 Blennius Species 0.000 abstract description 14
- 239000002904 solvent Substances 0.000 abstract description 11
- 244000308180 Brassica oleracea var. italica Species 0.000 abstract 1
- 210000004209 hair Anatomy 0.000 description 34
- 230000000694 effects Effects 0.000 description 27
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 26
- 201000004384 Alopecia Diseases 0.000 description 20
- 239000000306 component Substances 0.000 description 15
- 230000003676 hair loss Effects 0.000 description 13
- 208000024963 hair loss Diseases 0.000 description 13
- 241000758789 Juglans Species 0.000 description 10
- 210000003780 hair follicle Anatomy 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 7
- 231100000360 alopecia Toxicity 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 7
- 229940069328 povidone Drugs 0.000 description 7
- 230000003659 hair regrowth Effects 0.000 description 6
- 230000002940 repellent Effects 0.000 description 6
- 239000005871 repellent Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000002500 effect on skin Effects 0.000 description 5
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 4
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 4
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 4
- 230000003698 anagen phase Effects 0.000 description 4
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 4
- 229960003632 minoxidil Drugs 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 101000856500 Bacillus subtilis subsp. natto Glutathione hydrolase proenzyme Proteins 0.000 description 3
- 235000011303 Brassica alboglabra Nutrition 0.000 description 3
- 240000007124 Brassica oleracea Species 0.000 description 3
- 235000011302 Brassica oleracea Nutrition 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000003658 preventing hair loss Effects 0.000 description 3
- 210000004918 root sheath Anatomy 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000004658 Medicago sativa Species 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229960004039 finasteride Drugs 0.000 description 2
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000001171 Brassica oleracea var gongylodes Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 241000220645 Leonotis nepetifolia Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 244000128884 Zier Kohl Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 230000003778 catagen phase Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000039 epithelial melanocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000003803 hair density Effects 0.000 description 1
- 230000003646 hair health Effects 0.000 description 1
- 210000004919 hair shaft Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000001208 inner root sheath cell Anatomy 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000034272 protein filaments Human genes 0.000 description 1
- 108091005974 protein filaments Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000003797 telogen phase Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/202—Algae extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
본 실시예는 검정깨분말 10 ~ 25 중량%, 다시마분말 5 ~ 15 중량%, 미역분말 1 ~ 10 중량%, 하수오분말 1 ~ 10 중량%, 호두분말 1 ~ 5 중량%, 두피 침투제 : 5 ~ 20 중량%, 브로콜리 추출물 0.1 ~ 3.0 중량%, 콜라비 새싹 추출물 0.1 ~ 3.0 중량%, 알킬페놀에톡실레이트 0.5 ~ 3 중량%, N-메타크릴록시-N-카르복시메탈피페리딘 3 ~ 5 중량% 및 용매 : 10~ 50 중량%를 포함하는 발모 촉진용 조성물에 관한 것이다.This embodiment is 10 to 25% by weight black sesame powder, 5 to 15% by weight kelp powder, 1 to 10% by weight seaweed powder, 1 to 10% by weight sewage powder, 1 to 5% by weight walnut powder, scalp penetrant: 5 ~ 20% by weight, Broccoli extract 0.1-3.0%, Krabi sprout extract 0.1-3.0%, alkylphenol ethoxylate 0.5-3%, N-methacryloxy-N-carboxymetalpiperidine 3-5% It relates to a composition for promoting hair growth comprising a% and a solvent: 10 to 50% by weight.
Description
본 실시예는 발모 촉진용 조성물에 관한 것이다.This embodiment relates to a composition for promoting hair growth.
이하에서 기술되는 내용은 본 실시예에 대한 배경 정보를 제공할 뿐 종래기술을 기재한 것은 아니다.The contents described below provide background information on the present embodiment, but do not describe the prior art.
모발(hair)은 피부 진피(skin dermis)의 모낭(hair follicle)에서 자라는 단백질 필라멘트이다. 모낭은 크게 모근 부분에 위치한 진피유두(dermal papilla), 진피유두를 둘러싼 기질(matrix), 그리고 근초(root sheath)의 구조로 되어 있다. 진피유두는 주로 결합조직(connective tissue)와 모세혈관으로 되어 있으며 모근을 둘러싸 영양분과 산소를 공급한다. 기질은 상피세포(epithelial cell)와 멜라닌형성세포(melanocyte)로 되어 있으며, 세포분열이 활발하게 일어난다. 여기서 분열된 세포들이 각화(keratinization)되면서 모발이 만들어지고 피부밖으로 자라게 된다. 근초는 내모근초(inner root sheath)와 외모근초(outer root sheath)가 있으며, 성장하고 있는 모발이 완전히 각화될 때까지 보호하고 피부표피까지 도달하게 하는 역할을 한다. 모발은 성장기/생장기(anagen)-퇴화기(catagen)-휴지기(telogen)-탈락기(자연탈모)를 거치면서 주기적으로 성장하고 빠지고 다시 자라나는 과정을 반복하게 된다. 모낭에서 모발 성장기가 시작되면서 모발이 자라는데, 외모근초 팽윤부(bulge)에 존재하는 줄기세포들이 활성화되어 초기 성장기 동안 새로운 기질을 형성하고, 상대적으로 미분화된 기저부 세포로부터 모발줄기(hair shaft)와 내모근초가 생성된다. 모발줄기의 크기와 길이는 각각 모낭의 크기와 모발 성장기의 지속시간에 비례하게 된다.Hair is a protein filament that grows in the hair follicle of the skin dermis. Hair follicles are largely composed of dermal papilla, matrix surrounding dermal papilla, and root sheath. The dermal papilla is mainly composed of connective tissue and capillaries, and surrounds the hair root to supply nutrients and oxygen. The matrix is composed of epithelial cells and melanocytes, and cell division actively occurs. Here, the divided cells keratinize, creating hair and growing out of the skin. Root sheath is an inner root sheath and outer root sheath, which serves to protect the growing hair until it is fully aerated and reach the skin epidermis. The hair grows, falls out and regrows periodically through the growth, anagen, catagen, telogen, and hair loss phases. The hair grows in the hair follicles as the hair grows, and stem cells in the hair follicle bulge are activated to form new substrates during the initial growth phase, and the hair shaft and inner hair from relatively undifferentiated basal cells. Hairy roots are produced. The size and length of the hair stem are proportional to the size of the hair follicle and the duration of the hair growth phase, respectively.
탈모증은 정상적으로 털이 있어야 하는 부분의 털이 밀도가 비정상적으로 낮거나 소실된 상태를 말하며, 크게 반흔성과 비반흔성으로 나뉜다. 반흔성 탈모증은 모낭이 파괴되고 섬유조직으로 회복되어 영구적 탈모 상태가 되는 것으로 외상, 화상, 종양, 수술 등으로 인한 흉터와 감염이 주요 원인이다. 비반흔성 탈모증은 조직이 섬유화되지 않고 모낭도 보존된 상태로, 원형 탈모증, 휴지기/생장기 탈모증, 여성형 탈모증, 남성형 유전성 안드로겐 탈모증 등이 있다. 탈모의 원인은 정확히 밝혀지지는 않았으나, 대기오염, 식이습관 등 환경적 요인과 유전적 요인, 스트레스, 호르몬 불균형, 자율신경계 및 혈액순환 장애, 과도한 피지 생성, 모근의 영양 결핍, 알레르기, 세균 감염, 노화 등 생리적 요인들이 복합적으로 작용하는 것으로 추정되고 있다. 탈모증은 과거 중장년층에서만 발생되었으나, 최근에는 20~30대의 젊은 층에서도 빈번하게 발생되고 있다.Alopecia refers to abnormally low or missing hair density in areas where hair should normally be present, and is classified into scars and non scars. Scar alopecia is hair loss and recovery to fibrous tissue that leads to permanent hair loss. Scarring and infection from trauma, burns, tumors, and surgery are the main causes. Non-cancerous alopecia is a condition in which tissues are not fibrotic and hair follicles are preserved, such as alopecia areata, resting / growth alopecia, feminine alopecia, and hereditary androgen alopecia. The cause of hair loss is not clear, but environmental and genetic factors such as air pollution, dietary habits, stress, hormonal imbalance, autonomic nervous system and blood circulation disorders, excessive sebum production, malnutrition of hair roots, allergies, bacterial infections, It is estimated that physiological factors such as aging work in combination. Alopecia occurred only in the middle and middle age group in the past, but recently occurs frequently among young people in their 20s and 30s.
이에 탈모 현상을 개선하고 발모를 촉진하기 위한 화장품 또는 제약 연구개발이 활발히 진행되어 왔으며, 현재 미국 식품의약국(FDA)의 의약품 허가를 받고 시판 중인 탈모 치료제로는 도포제인 미녹시딜(minoxidil)과 경구용 피나스테라이드(finasteride)가 있다. 미녹시딜은 혈관을 확장시켜 혈류량을 증가시키고 모근에 영양분을 공급함으로써 모발 성장을 유도하며, 피나스테라이드는 II형 5?-환원효소의 특정억제제로 테스토스테론이 디하이드로테스토스테론(dihydrotestosterone)으로 전환되는 것을 방지함으로써 탈모를 억제하는 것으로 알려져 있다.Therefore, cosmetics or pharmaceutical research and development has been actively conducted to improve the hair loss phenomenon and promote hair growth. Currently, the hair loss treatment agent approved by the US Food and Drug Administration (FDA) and the commercially available hair loss treatment agent are minoxidil and oral There is finasteride. Minoxidil induces hair growth by expanding blood vessels to increase blood flow and nourish hair roots, while finasteride is a specific inhibitor of type II 5-reductase that prevents testosterone from converting to dihydrotestosterone. It is known to suppress.
이들 발모 치료제는 모근이 활성화 되어 있는 부위에서만 효과가 있기 때문에 탈모를 예방하는데는 효과가 있지만 장기간 휴지기 상태에 있는 모발의 성장 효과는 미미하거나, 투약하는 동안에만 효과가 지속되는 등의 단점이 있다. 특히 남성호르몬을 조절하는 약물은 성욕감퇴, 발기부전 등의 부작용이 나타날 수 있다. 이에 탈모를 예방하고 모발 성장을 촉진하며, 그 효과가 안정적으로 유지될 수 있고, 부작용은 적은 안전하고 경제적인 발모 촉진 기술 개발이 필요하다.These hair regrowth treatments are effective in preventing hair loss because they are effective only in the area where the hair root is activated, but the growth effects of the hair in a long-term rest period are insignificant, or the effects last only during administration. In particular, drugs that regulate male hormones may cause side effects such as decreased libido and erectile dysfunction. Therefore, it is necessary to develop a safe and economical hair growth promoting technology that prevents hair loss and promotes hair growth, the effect can be maintained stably, and side effects are low.
본 실시예는 모발 성장을 촉진하고, 탈모를 일으킬 수 있는 피부 염증을 억제할 수 있는 천연 물질에 대하여 연구하던 중, 콜라비 새싹 추출물, 브로콜리 새싹 추출물과 해산물인 다시마 분말 및 미역 분말을 합성하고 두피 침투제는 트리톤-X(Triton-X) 또는 포비돈을 사용하여 발모 촉진 효과와 항염증 효과가 있는 조성물을 제공하고자 한다.In the present embodiment, while studying natural substances capable of promoting hair growth and inhibiting skin inflammation that can cause hair loss, a collagen sprout extract, broccoli sprout extract, seaweed kelp powder, and seaweed powder are synthesized. Penetrants use Triton-X or povidone to provide compositions having hair growth promoting and anti-inflammatory effects.
본 발명에 따른 발모 촉진용 조성물은 검정깨분말 10 ~ 25 중량%, 다시마분말 5 ~ 15 중량%, 미역분말 1 ~ 10 중량%, 하수오분말 1 ~ 10 중량%, 호두분말 1 ~ 5 중량%, 두피 침투제 : 5 ~ 20 중량%, 브로콜리 추출물 0.1 ~ 3.0 중량%, 콜라비 새싹 추출물 0.1 ~ 3.0 중량%, 알킬페놀에톡실레이트 0.5 ~ 3 중량%, N-메타크릴록시-N-카르복시메탈피페리딘 3 ~ 5 중량% 및 용매 : 10~ 50 중량%를 포함한다.The hair growth promoting composition according to the present invention is black sesame powder 10 to 25% by weight, kelp powder 5 to 15% by weight, seaweed powder 1 to 10% by weight, sewage powder 1 to 10% by weight, walnut powder 1 to 5% by weight, Scalp Penetrant: 5-20 wt%, Broccoli Extract 0.1-3.0 wt%, Krabi Sprout Extract 0.1-3.0 wt%, Alkylphenolethoxylate 0.5-3 wt%, N-methacryloxy-N-carboxymetalpiperi 3 to 5 wt% of dean and 10 to 50 wt% of solvent.
상기 두피 침투제는 트리톤-X(Triton-X) 또는 포비돈을 사용할 수 있고, 상기 브로콜리 추출물과 콜라비 새싹 추출물은 1: 0.5 ~ 1: 0.8의 중량비로 첨가되는 것을 특징으로 하고, 더욱 바람직하게는 상기 브로콜리 추출물과 콜라비 새싹 추출물은 1: 0.61의 중량비로 첨가될 수 있다.The scalp penetration agent may use Triton-X or povidone, and the broccoli extract and the kohlrabi sprout extract are added in a weight ratio of 1: 0.5 to 1: 0.8, and more preferably, Broccoli extract and kohlrabi sprout extract may be added in a weight ratio of 1: 0.61.
본 실시예를 통해, 콜라비 추출물, 브로콜리 추출물을 사용하고, 두피침투제로 트리톤-X(Triton-X) 또는 포비돈을 포함하는 모발 성장 촉진용 및 항염증용 식품용 조성물과 화장료 조성물을 제공한다. 본 발명의 조성물은 피부에서 모발 성장을 촉진하는 인자를 활성도 및/또는 발현을 증가시키는 효과가 있어 모발 생장을 증진하는 피부 환경을 조성하며, 탈모와 비듬을 일으킬 수 있는 피부 염증을 억제하는 탁월한 효과가 있다.Through this embodiment, using the Kohlrabi extract, broccoli extract, and provides a hair growth promoting and anti-inflammatory food composition and cosmetic composition comprising Triton-X (Priton-X) or povidone as a scalp penetration agent. The composition of the present invention has the effect of increasing the activity and / or expression of the factors that promote hair growth in the skin to create a skin environment to promote hair growth, and excellent effect of inhibiting skin inflammation that can cause hair loss and dandruff There is.
이하에서는 설명의 편의를 위해 본 발명의 일부 실시 예를 예시적인 도면을 통해 설명한다. 다만, 본 발명의 기술 사상은 설명되는 일부 실시 예에 한정되지 않는다.Hereinafter, some embodiments of the present invention will be described through exemplary drawings for the convenience of description. However, the technical idea of the present invention is not limited to some embodiments described.
또한, 본 발명의 실시 예의 구성 요소를 설명하는 데 있어서, 제1, 제2, A, B, (a), (b) 등의 용어를 사용할 수 있다. 이러한 용어는 그 구성 요소를 다른 구성 요소와 구별하기 위한 것일 뿐, 그 용어에 의해 해당 구성 요소의 본질이나 차례 또는 순서 등이 한정되지 않는다. In addition, in describing the components of the embodiments of the present disclosure, terms such as first, second, A, B, (a), and (b) may be used. These terms are only for distinguishing the components from other components, and the nature, order or order of the components are not limited by the terms.
어떤 구성 요소가 다른 구성요소에 '연결' 또는 '결합'된다고 기재된 경우, 그 구성 요소는 그 다른 구성요소에 직접적으로 연결 또는 결합될 수 있지만, 그 구성 요소와 그 다른 구성요소 사이에 또 다른 구성 요소가 '연결' 또는 '결합'될 수도 있다고 이해되어야 할 것이다.When a component is described as being 'connected' or 'coupled' to another component, the component may be directly connected or coupled to the other component, but there is another component between the component and the other component. It is to be understood that the elements may be 'connected' or 'coupled'.
발모 촉진용 조성물Hair growth promoting composition
본 발명의 실시예에 따른 발모 촉진용 조성물은 검정깨분말 10 ~ 25 중량%, 다시마분말 5 ~ 15 중량%, 미역분말 1 ~ 10 중량%, 하수오분말 1 ~ 10 중량%, 호두분말 1 ~ 5 중량%, 두피 침투제 : 5 ~ 20 중량%, 브로콜리 추출물 0.1 ~ 3.0 중량%, 콜라비 새싹 추출물 0.1 ~ 3.0 중량%, 알킬페놀에톡실레이트 0.5 ~ 3 중량%, N-메타크릴록시-N-카르복시메탈피페리딘 3 ~ 5 중량% 및 용매 : 10~ 50 중량%를 포함한다.Hair growth promoting composition according to an embodiment of the present invention is black sesame powder 10 to 25% by weight, kelp powder 5 to 15% by weight, seaweed powder 1 to 10% by weight, sewage powder 1 to 10% by weight, walnut powder 1 to 5 Weight%, Scalp Penetrating Agent: 5-20% by weight, Broccoli Extract 0.1-3.0% by weight, Krabi sprout extract 0.1-3.0% by weight, 0.5-3% by weight of alkylphenolethoxylate, N-methacryloxy-N-carboxy Metal piperidine 3 to 5% by weight and solvent: 10 to 50% by weight.
검정콩은 일반 콩과 비교하여 영양소의 함량은 비슷하지만 노화방지성분이 4배나 많고, 성인병 예방에 효과가 있다. 특히, 모발 성장에 필수 요소인 시스테인(cysteine)이 함유되어 있어 탈모를 방지하는 데도 효과가 있다. 이러한 검정콩은 지속적으로 복용하면 신장과 방광의 기능을 원활하게 해준다. 검은 깨의 지질 성분은 혈관과 두피에 영양을 공급하는 작용을 한다. 이 외에도 검은 깨에는 리놀렌산, 리놀레인산 등 불포화 지방산과 아미노산, 비타민E, 칼슘, 철분, 비타민B1 및 B2가 골고루 들어 있어 모발 건강에 도움을 준다. 따라서, 검정깨분말은 본 발명의 실시예에 따른 발모 촉진용 조성물 전체 중량의 10 ~ 25 중량%의 함량비로 첨가되는 것이 바람직하다.Black soybeans are similar in nutrient content compared to regular soybeans, but four times more anti-aging ingredients and effective in preventing adult diseases. In particular, cysteine (cysteine), which is essential for hair growth, is effective in preventing hair loss. These black beans can help your kidneys and bladder function when taken continuously. Black sesame lipids nourish blood vessels and scalp. In addition, black sesame seeds contain a mixture of unsaturated fatty acids such as linolenic acid and linoleic acid, as well as amino acids, vitamin E, calcium, iron, vitamins B1 and B2, to help with hair health. Therefore, black sesame powder is preferably added in an amount of 10 to 25% by weight of the total weight of the composition for promoting hair growth according to an embodiment of the present invention.
다시마는 강장제로 신장을 보호하며 탈모예방, 발모촉진 효과가 있으며 요오드 함량이 해조류 중에서 가장 많으며 칼슘(Ca) 및 인(P)의 함량이 많다. 또한, 다시마는 혈중 콜레스테롤을 낮추며 장의 활동을 도우며, 뼈의 성장발육을 빠르게 한다. 따라서, 다시마분말은 본 발명의 실시예에 따른 발모 촉진용 조성물 전체 중량의 5 ~ 15 중량%의 함량비로 첨가되는 것이 바람직하다.Kelp is a tonic that protects the kidneys, prevents hair loss, promotes hair growth, and has the highest iodine content among seaweeds, and has a high content of calcium (Ca) and phosphorus (P). In addition, kelp lowers blood cholesterol, helps intestinal activity, and accelerates bone growth. Therefore, the kelp powder is preferably added in a content ratio of 5 to 15% by weight of the total weight of the hair growth promoting composition according to an embodiment of the present invention.
미역은 다량의 무기질을 함유하고 있어 체내 수분의 흐름을 조정하며 해산을 쉽게 하고 부인병을 치료하며 고혈압, 동맥경화 비만예방에 좋으며 갑상선호르몬인 티록신을 공급한다. 따라서, 미역분말은 본 발명의 실시예에 따른 발모 촉진용 조성물 전체 중량의 1 ~ 10 중량%의 함량비로 첨가되는 것이 바람직하다.Seaweed contains a large amount of minerals to regulate the flow of water in the body, ease dissolution, treat gynecological diseases, prevent hypertension and atherosclerosis obesity, and supply thyroid hormone thyroxine. Therefore, the seaweed powder is preferably added in an amount of 1 to 10% by weight of the total weight of the composition for promoting hair growth according to an embodiment of the present invention.
하수오는 강장효과가 뛰어나 간장과 신장의 기능을 튼튼하게 해주고 근골을 튼튼하게 해주며 탈모증 예방과, 치료의 효과가 뛰어나다. 따라서, 하수오분말은 본 발명의 실시예에 따른 발모 촉진용 조성물 전체 중량의 1 ~ 10 중량%의 함량비로 첨가되는 것이 바람직하다.Sewage has excellent tonic effect, strengthening the function of liver and kidney, strengthening the musculature, preventing hair loss and treating. Therefore, sewage powder is preferably added in an amount of 1 to 10% by weight of the total weight of the composition for promoting hair growth according to an embodiment of the present invention.
호두는 질 좋은 단백질과 불포화 지방산이 다량 함유되어 있으며, 비타민과 미네랄이 풍부하여 탈모를 방지하는데 효과가 있다. 이러한 호두는 본 발명의 실시예에 따른 발모 촉진용 조성물 전체 중량의 1 ~ 5 중량%의 함량비로 첨가되는 것이 바람직하다.Walnuts are rich in high quality proteins and unsaturated fatty acids, and are rich in vitamins and minerals to help prevent hair loss. Such walnut is preferably added in an amount of 1 to 5% by weight of the total weight of the composition for promoting hair growth according to an embodiment of the present invention.
두피 침투제는 디메틸 설폭사이드(dimethyl sulfoxide, DMSO), 트리톤 X(Triton-X) 또는 포비돈을 사용하며, 두피 깊숙한 진피층으로의 약제 성분의 침투 효과를 증강하기 위해 사용한다. 특히, 피부자극제인 멘톨을 추가하여 피부 자극성을 증가하면 약제 성분의 피부 진피층으로의 작용 효능을 더욱 증대한다. 이때, 디메틸 설폭사이드, 트리톤-X, 포비돈 등의 두피 침투제는 최종 조성물 전체 중량에 대하여 각각 1 내지 20 중량%로, 멘톨 등의 피부 자극제는 최종 조성물 전체 중량으로 1~5 중량%로 포함되는 것이 바람직하며, 특히 두피 침투제인 디메틸 설폭사이드, 트리톤-X 및 포비돈은 각각 별도로 사용할 경우, 최종 조성물 전체 중량에 대하여 디메틸 설폭사이드는 1.0 내지 20 중량%, 트리톤-X는 1.0 내지 10.0중량% 및 포비돈은 1.0 내지 5.0 중량%으로 포함되는 것이 바람직하다. 특히, 대머리 등의 오래된 두피층은 보통의 약효 성분이 침투하기 어렵기 때문에, 많은 종류의발모, 육모제가 그 효능을 발휘하지 못하는 주요 원인이 되기도 한다. 그 중, 두피 침투제로서 디메틸 설폭사이드(DMSO)가 바람직하며, DMSO는 저분자 화합물로서, 생체막을 잘 통과하고, 다른 물질들의 세포막 투과도를 증가시키는 특성이 있다. 또한, DMSO는 하이드록시 라디칼(OH')을 제거시키는 항산화 작용도 있다. DMSO는 물, 알코올 기타 거의 모든 유기, 생화학 물질을 용해하는 뛰어난 장점이 있어, 핵자기 공명 분석기 등에서 생체 고분자의 용매로 널리 사용되고 있기도 하다. DMSO가 두피 침투를 돕는 기전은 확실하게 규명되지는 않았으나, 탁월한 용해력으로 단백질 등 고분자를 순간적으로 녹이는 기능에 기인하는 것으로 사료된다.Scalp penetrants use dimethyl sulfoxide (DMSO), Triton-X or povidone, and are used to enhance the penetration of pharmaceutical components into the dermal layer deep into the scalp. In particular, the addition of menthol, a skin stimulant, increases skin irritation, which further enhances the effect of the pharmaceutical ingredient on the dermal layer of the skin. At this time, the scalp penetrants such as dimethyl sulfoxide, Triton-X, povidone, etc. are each contained in an amount of 1 to 20% by weight based on the total weight of the final composition, and skin irritants such as menthol are included in 1 to 5% by weight of the total weight of the final composition. Preferred, especially when the scalp penetrants dimethyl sulfoxide, Triton-X and povidone are used separately, 1.0 to 20% by weight of dimethyl sulfoxide, 1.0 to 10.0% by weight of triton-X and povidone relative to the total weight of the final composition It is preferably included in 1.0 to 5.0% by weight. In particular, the old scalp layer, such as bald head is difficult to penetrate the usual active ingredients, many kinds of hair growth, hair growth agent is also a major cause that does not exhibit its efficacy. Among them, dimethyl sulfoxide (DMSO) is preferable as a scalp penetrant, and DMSO is a low molecular compound, which has a property of passing through a biological membrane well and increasing cell membrane permeability of other substances. DMSO also has an antioxidant action that removes hydroxy radicals (OH '). DMSO has the advantage of dissolving water, alcohol and almost all organic and biochemicals, and is widely used as a solvent for biopolymers in nuclear magnetic resonance analyzers. The mechanism by which DMSO helps infiltrate the scalp has not been elucidated, but it is believed to be due to the ability to instantly dissolve polymers such as proteins with excellent dissolving power.
본 발명은 콜라비 새싹 추출물이 피부에서 감마-글루타밀 트랜스펩티다제(γ-glutamyl transpeptidase), 알칼리성 인산분해효소(ALP), 표피성장인자(EGF), 혈관내피세포성장인자(VEGF) 등 모발 성장을 유도하는 인자의 활성 및/또는 발현량을 높여서 모발 성장을 촉진하는 피부 환경을 조성하며, 탈모와 비듬의 원인이 될 수 있는 피부 염증을 억제하는데 탁월한 효과가 있음을 발견하였다. 특히 상기 조성물에 브로콜리 새싹 추출물, 다시마 추출물을 추가로 포함하는 경우 모발성장 촉진과 항염증 효과가 더욱 상승하는 것을 발견하였고, 또한 식물과 해조류의 혼합 추출물 조성물의 효과를 이용하여 안전하고 효과 지속적인 모발 성장 촉진용 및 항염증용 식품을 개발하는데 이용할 수 있다.The present invention is a collagen sprout extract hair gamma-glutamyl transpeptidase (γ-glutamyl transpeptidase), alkaline phosphatase (ALP), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF) hair Increasing the amount of activity and / or expression of the factors that induce growth to create a skin environment that promotes hair growth, has been found to have an excellent effect in inhibiting skin inflammation that can cause hair loss and dandruff. In particular, the broccoli sprout extract, the kelp extract in addition to the composition was found to further increase the hair growth and anti-inflammatory effect, and also by using the effect of the mixed extract composition of plants and algae safe and effective hair growth It can be used to develop foods for promotion and anti-inflammatory.
본 발명에서' 콜라비(kohlrabi)'는 브라시카 올레라케아 속의 곤길로데스(Brassica oleracea spp Gongylodes)그룹에 속하는 품종의 식물로, 독일 순무(german turnip) 또는 순무 양배추(turnip cabbage)라고도 불리는 작물이다. 콜라비의 잎과 연녹색 또는 자주색을 띠는 구근(덩이 줄기)을 식용으로 사용한다. 본 발명에서의 콜라비는 콜라비 또는 콜라비의 새싹일 수 있다.In the present invention, 'kohlrabi' is a plant belonging to the group belonging to the group of Brassica oleracea spp Gongylodes of the genus Brassica oleracea, which is also called a German turnip or turnip cabbage. to be. Kohlabi leaves and light green or purple bulbs (tube stems) are used for food. The kohlrabi in the present invention may be kohlrabi or sprout of kohlrabi.
본 발명에서 '브로콜리(broccoli)'는 브라시카 올레라케아(Brassica oleracea)에 속하는 식물로, 녹색꽃양배추라고도 불린다. 꽃 부분을 먹는 양배추 중의 한 종류가 이탈리아에서 품종개량되기 시작하여 꽃의 발달이 억제되도록 육종되어 두꺼운 줄기(stalk)로부터 수많은 꽃눈(floret)이 달린 현재의 모습을 갖게 되었다. 줄기와 꽃눈을 모두 식용으로 한다. 본 발명에서의 브로콜리는 브로콜리 또는 브로콜리의 새싹일 수 있다.In the present invention, 'broccoli' is a plant belonging to Brassica oleracea, also called green cauliflower. One type of flowering cabbage began to be bred in Italy, where it was bred to suppress the development of the flower, giving it a present appearance with numerous florets from thick stalks. Both stem and flower eyes are eaten. Broccoli in the present invention may be broccoli or sprout of broccoli.
본 발명에 따른 화장료 조성물은 콜라비 추출물 이외에 모발 성장 촉진과 항염증의 효과를 더욱 극대화하기 위하여 추가적으로 브로콜리 추출물 및 다시마 추출물로 이루어진 군에서 선택된 하나 이상의 추출물을 더욱 포함할 수도 있다. 상기 브로콜리 추출물과 콜라비 새싹 추출물은 1: 0.5 ~ 1: 0.8의 중량비로 첨가되는 것이 바람직하다.The cosmetic composition according to the present invention may further include at least one extract selected from the group consisting of broccoli extract and kelp extract in order to further maximize the effect of hair growth and anti-inflammatory in addition to the kohlrabi extract. The broccoli extract and kohlrabi sprout extract is preferably added in a weight ratio of 1: 0.5 ~ 1: 0.8.
본 실시예에서 콜라비 추출물과 브로콜리 추출물은 각각의 새싹을 이용하였다. 콜라비 새싹 추출물은 70% 에탄올 수용액으로 용매 추출하여 살균하고 농축 및 건조하여 분말로 제조하였다. 브로콜리 새싹 추출물은 브로콜리 새싹을 세정하고 건조한 후 분쇄하여 40℃에서 70% 에탄올 수용액으로 용매 추출하고 살균하여 농축 및 건조하는 과정을 거쳐 분말로 제조하였다. 다시마 추출물은 다시마를 세정하고 건조 및 분쇄하여 60℃에서 하루 동안 열수 추출한 후, 0.45㎛의 막으로 여과한 뒤 살균하고 농축 및 분무건조하여 분말로 제조하였다.In this example, the kohlrabi extract and broccoli extract was used for each shoot. The kohlrabi sprout extract was sterilized by solvent extraction with an aqueous 70% ethanol solution, concentrated and dried to prepare a powder. Broccoli sprout extract was prepared by washing the broccoli sprout, dried and pulverized, solvent extraction with 70% ethanol aqueous solution at 40 ° C., sterilization, concentration and drying. Kelp extract was washed with seaweed, dried and pulverized, extracted with hot water at 60 ° C. for one day, filtered through a membrane of 0.45 μm, sterilized, concentrated and spray dried to prepare a powder.
복합 추출물이 모발 성장에 미치는 영향Effect of Complex Extracts on Hair Growth
γ-Glutamyl transpeptidase 활성도 측정γ-Glutamyl transpeptidase activity measurement
콜라비 새싹 추출물, 브로콜리 새싹 추출물, 다시마 추출물의 단독 추출물 또는 혼합물이 γ-glutamyl transpeptidase(γ-GTP)의 활성도에 미치는 영향을 알아보았다. γ-GTP는 모낭에서 모근을 생장기(anagen)로 유도하는 기능을 하는 것으로 알려진 모발 성장에 중요한 효소이다. 실험조건에 따라 각각의 추출물을 단독으로 또는 혼합하여 마우스에 14일 동안 경구투여하고, 마우스 피부에서의 γ-GTP 활성도를 측정하였다.The effect of Kolbi sprout extract, broccoli sprout extract, and kelp extract alone or mixture on the activity of γ-glutamyl transpeptidase (γ-GTP) was investigated. γ-GTP is an important enzyme for hair growth known to function in the hair follicles to induce hair follicles into the anagen. Depending on the experimental conditions, each extract was administered orally to mice alone or mixed for 14 days, and γ-GTP activity in the skin of the mice was measured.
콜라비 새싹 추출물, 브로콜리 새싹 추출물, 다시마 추출물을 각각 단독으로 처리한 경우 대조군(Normal)과 비교하여 γGTP 활성도가 증가하는 경향을 나타내었다. 한편 콜라비 새싹 추출물 그리고 브로콜리 새싹 추출물을 함께 투여한 경우(콜라비+브로콜리)에는 대조군과 비교하여 γGTP 활성도가 통계적으로 유의한 증가를 나타내었다. 또한 알팔파 새싹 추출물, 콜라비 새싹 추출물, 브로콜리 새싹 추출물, 시스탄체 투불로사 추출물, 다시마 추출물을 모두 포함하는 복합 추출물(복합 조성물 1과 2)을 투여했을 때는 각각의 단독 추출물이나 알팔파 새싹 추출물, 콜라비 새싹 추출물, 브로콜리 새싹 추출물 혼합 조성물보다도 가장 뛰어난 γGTP 활성도 증가 효과를 나타내었다. 특히 기존의 발모제인 미녹시딜(Minoxidil, 3%)와 비교하여서도 유사한 수준을 보였다.In the case of treatment of the kohlrabi sprout extract, broccoli sprout extract, and kelp extracts alone, the γGTP activity tended to increase compared to the control (Normal). On the other hand, when administered together with the kohlrabi sprout extract and broccoli sprout extract (collabi + broccoli) showed a statistically significant increase in γGTP activity compared to the control. In addition, when a complex extract (composite composition 1 and 2) containing all of alfalfa sprout extract, kohlrabi sprout extract, broccoli sprout extract, cystane tubulosa extract, and kelp extract, each of the single extract or alfalfa sprout extract, cola It showed the most excellent effect of increasing the γGTP activity than the rain sprout extract, broccoli sprout extract composition. In particular, compared to the existing hair regrowth minoxidil (Minoxidil, 3%) showed a similar level.
이상의 실험 결과는 콜라비 새싹 추출물의 혼합 조성물에 γGTP 활성도를 증가시키는 효과가 있으며, 특히 콜라비 새싹 추출물에 브로콜리 새싹 추출물, 다시마 추출물을 더욱 포함하면 추출물의 혼합에 의한 상승 효과로 인해 γGTP 활성도가 최대화되는 것을 알 수 있다The above experimental results have the effect of increasing the γGTP activity in the mixed composition of the kohlrabi sprout extract, especially if the broccoli sprout extract, kelp extract is further included in the kohlrabi sprout extract to maximize the γGTP activity due to the synergistic effect of the extract mixture I can see
발모제 조성물 제조Hair Regrowth Composition Preparation
실시예 1Example 1
검정깨분말 20 중량%, 다시마분말 10 중량%, 미역분말 5 중량%, 하수오분말 7 중량%, 호두분말 4 중량%, 두피침투제로 트리톤-X(Triton-X) 15 중량%, 브로콜리 추출물 2.0 중량%, 콜라비 새싹 추출물 1.2 중량%, 알킬페놀에톡실레이트 3 중량%, N-메타크릴록시-N-카르복시메탈피페리딘 3 중량% 및 용매로 정제수 38 중량%를 혼합한 후, 30분 동안 교반하여 발모제 조성물을 제조하였다.Black sesame powder 20%, kelp powder 10% by weight, seaweed powder 5% by weight, sewage powder 7% by weight, walnut powder 4% by weight, 15% by weight of Triton-X as a scalp penetrant, broccoli extract 2.0% by weight %, Kohlrabi sprout extract 1.2% by weight, alkylphenol ethoxylate 3% by weight, N- methacryloxy-N- carboxymetalpiperidine and 38% by weight of purified water in a solvent and then mixed for 30 minutes Stirring prepared the hair repellent composition.
실시예 2Example 2
검정깨분말 21 중량%, 다시마분말 11 중량%, 미역분말 4중량%, 하수오분말 6 중량%, 호두분말 4 중량%, 두피침투제로 트리톤-X(Triton-X) 15 중량%, 브로콜리 추출물 2.0 중량%, 콜라비 새싹 추출물 1.8 중량%, 알킬페놀에톡실레이트 3 중량%, N-메타크릴록시-N-카르복시메탈피페리딘 3 중량% 및 용매로 정제수 38 중량%를 혼합한 후, 30분 동안 교반하여 발모제 조성물을 제조하였다.Black sesame powder 21%, kelp powder 11% by weight, seaweed powder 4% by weight, sewage powder 6% by weight, walnut powder 4% by weight, 15% by weight of Triton-X as a scalp penetrant, broccoli extract 2.0% by weight %, Kolabi sprout extract 1.8% by weight, alkylphenol ethoxylate 3% by weight, N-methacryloxy-N-carboxymetalpiperidine and 38% by weight of purified water in a solvent, and then 30 minutes Stirring prepared the hair repellent composition.
실시예 3Example 3
검정깨분말 22중량%, 다시마분말 10 중량%, 미역분말 5 중량%, 하수오분말 7 중량%, 호두분말 4 중량%, 두피침투제로 트리톤-X(Triton-X) 15 중량%, 브로콜리 추출물 2.5 중량%, 콜라비 새싹 추출물 1.0 중량%, 알킬페놀에톡실레이트 3 중량%, N-메타크릴록시-N-카르복시메탈피페리딘 3 중량% 및 용매로 정제수 38 중량%를 혼합한 후, 30분 동안 교반하여 발모제 조성물을 제조하였다.Black sesame powder 22%, kelp powder 10% by weight, seaweed powder 5% by weight, sewage powder 7% by weight, walnut powder 4% by weight, 15% by weight of Triton-X as a scalp penetration agent, 2.5% by weight broccoli extract %, Kohlrabi sprout extract 1.0% by weight, alkylphenol ethoxylate 3% by weight, N- methacryloxy-N-carboxymetal piperidine and 38% by weight of purified water in a solvent, and then mixed for 30 minutes Stirring prepared the hair repellent composition.
실시예 4Example 4
검정깨분말 20 중량%, 다시마분말 10 중량%, 미역분말 5 중량%, 하수오분말 7 중량%, 호두분말 4 중량%, 두피침투제로 트리톤-X(Triton-X) 15 중량%, 브로콜리 추출물 3.0 중량%, 콜라비 새싹 추출물 1.7 중량%, 알킬페놀에톡실레이트 3 중량%, N-메타크릴록시-N-카르복시메탈피페리딘 3 중량% 및 용매로 정제수 38 중량%를 혼합한 후, 30분 동안 교반하여 발모제 조성물을 제조하였다.Black sesame powder 20%, kelp powder 10% by weight, brown seaweed powder 5% by weight, sewage powder 7% by weight, walnut powder 4% by weight, 15% by weight of Triton-X as a scalp penetration agent, 3.0% broccoli extract %, Kolabi sprout extract 1.7% by weight, alkylphenol ethoxylate 3% by weight, N-methacryloxy-N-carboxymetalpiperidine and 38% by weight of purified water in a solvent, followed by 30 minutes Stirring prepared the hair repellent composition.
실시예 5Example 5
검정깨분말 20 중량%, 다시마분말 10 중량%, 미역분말 5 중량%, 하수오분말 7 중량%, 호두분말 4 중량%, 두피침투제로 트리톤-X(Triton-X) 15 중량%, 브로콜리 추출물 3.0 중량%, 콜라비 새싹 추출물 1.85 중량%, 알킬페놀에톡실레이트 3 중량%, N-메타크릴록시-N-카르복시메탈피페리딘 3 중량% 및 용매로 정제수 38 중량%를 혼합한 후, 30분 동안 교반하여 발모제 조성물을 제조하였다.Black sesame powder 20%, kelp powder 10% by weight, brown seaweed powder 5% by weight, sewage powder 7% by weight, walnut powder 4% by weight, 15% by weight of Triton-X as a scalp penetration agent, 3.0% broccoli extract %, Kolavi sprout extract 1.85% by weight, alkylphenol ethoxylate 3% by weight, N-methacryloxy-N-carboxymetal piperidine and 38% by weight of purified water in a solvent, and then mixed for 30 minutes Stirring prepared the hair repellent composition.
비교예 1Comparative Example 1
검정깨분말 22 중량%, 다시마분말 11 중량%, 미역분말 6 중량%, 하수오분말 8 중량%, 호두분말 5 중량%, 두피침투제로 디메틸 설폭사이드(dimethyl sulfoxide) 15 중량% 및 용매로 정제수 33 중량%를 혼합한 후, 30분 동안 교반하여 발모제 조성물을 제조하였다.22% by weight of black sesame powder, 11% by weight of kelp powder, 6% by weight of seaweed powder, 8% by weight of sewage powder, 5% by weight of walnut powder, 15% by weight of dimethyl sulfoxide as scalp penetrant and 33% by weight of purified water as solvent After mixing the%, stirring for 30 minutes to prepare a hair restorer composition.
비교예 2Comparative Example 2
검정깨분말 22 중량%, 다시마분말 12 중량%, 미역분말 8 중량%, 하수오분말 9 중량%, 호두분말 5 중량%, 두피침투제로 디메틸 설폭사이드(dimethyl sulfoxide) 15 중량%, 콜라겐 추출물 1.0 중량% 및 용매로 정제수 28 중량%를 혼합한 후, 30분 동안 교반하여 발모제 조성물을 제조하였다.Black sesame powder 22%, kelp powder 12% by weight, seaweed powder 8% by weight, sewage powder 9% by weight, walnut powder 5% by weight, 15% by weight of dimethyl sulfoxide as a scalp penetration agent, 1.0% by weight of collagen extract And after mixing 28% by weight of purified water with a solvent, and stirred for 30 minutes to prepare a hair restorer composition.
물성 평가Property evaluation
표 1은 실시예 1 ~ 5 및 비교예 1 ~ 2에 따라 제조된 발모제 조성물에 대한 모발 성장 촉진 효능 시험에 대한 측정결과를 나타낸 것이다.Table 1 shows the measurement results for the hair growth promoting efficacy test for the hair regrowth composition prepared according to Examples 1 to 5 and Comparative Examples 1 to 2.
6주령의 마우스 수컷 60마리를 7일 동안 온도 22℃ 및 상대습도 50% 조건의 실험실에서 적응시킨 후, 건강한 마우스 수컷 35마리만을 선택하여 시험에 사용하였다. 음용수로는 증류수를 자유 섭취시켰고 사료로는 실험동물용사료를 자유 섭취시켰다. 선택된 마우스 수컷을 무작위 선택하는 방법으로 5 마리씩 7군으로 분배하여 칸막이에 가둔 후, 목뒤에서 꼬리 부분까지 등의 털을 완전히 제거하였다. 제모 후 1일 동안 방치한 후, 7군으로 분배된 5마리의 마우스 수컷에 대하여 실시예 1 ~ 5 및 비교예 1 ~ 2에 따라 제조된 발모제 조성물 10ml를 면봉을 사용하여 마우스 수컷의 제모한 등에 고르게 도포하였다.Sixty-week-old mouse males were acclimated for seven days in a laboratory at a temperature of 22 ° C. and a relative humidity of 50%, and then only 35 healthy mouse males were selected and used for testing. Distilled water was freely consumed as drinking water and experimental animal feed was freely consumed as feed. The selected male males were divided into seven groups of five by randomly selecting them, placed in a partition, and completely removed the back hair from the back of the neck to the tail. After 1 day of depilation, 10 ml of the hair repellent composition prepared according to Examples 1 to 5 and Comparative Examples 1 to 2 were applied to 5 mouse males distributed in 7 groups using a cotton swab, etc. Apply evenly.
이때, 도포 15일 및 30일경화 후 마우스 수컷들의 털을 목뒤 2cm, 등 한가운데, 꼬리 위 1cm 별로 뽑아 확대경으로 마우스 수컷 털의 평균 두께 및 길이를 각각 측정하였다.At this time, after 15 days and 30 days of application, the hairs of the male males were 2cm behind the neck, and the center of the back.
표 1에 도시된 바와 같이, 실시예 1 ~ 5에 따라 제조된 조성물을 도포할 시, 시간의 경과에 따라 모발 두께 및 모발 길이에 큰 효과를 나타나는 것을 확인할 수 있다.As shown in Table 1, when applying the composition prepared according to Examples 1 to 5, it can be seen that a great effect on the hair thickness and hair length over time.
반면, 비교예 1 ~ 2에 따라 제조된 발모제 조성물을 도포할 시에는 모발 두께 및 모발 길이에 큰 변화가 없는 것을 확인할 수 있다.On the other hand, when applying the hair regrowth composition prepared according to Comparative Examples 1 to 2 it can be confirmed that there is no significant change in hair thickness and hair length.
위의 실험 결과를 토대로 알 수 있는 바와 같이, 실시예 1 ~ 5에 따라 제조된 발모제 조성물을 이용할시, 모발 성장 촉진 효능이 있다는 것을 확인하였다. 특히, 실시예 4에서 브로콜리 추출물 3.0 중량%, 콜라비 새싹 추출물 1.7 중량%을 포함하는 조성물을 실시하였고, 실시예 5에서는 브로콜리 추출물 3.0 중량%, 콜라비 새싹 추출물 1.85 중량%을 사용한 경우 더욱 탁월한 효과가 있는 것을 알 수 있다.As can be seen based on the above experimental results, it was confirmed that the hair growth promoting effect when using the hair regrowth composition prepared according to Examples 1 to 5. Particularly, in Example 4, a composition comprising 3.0 wt% broccoli extract and 1.7 wt% of kohlrabi sprout extract was carried out, and in Example 5, when the broccoli extract 3.0 wt% and the kohlrabi sprout extract 1.85 wt% were used, the effect was more excellent. You can see that there is.
이와 같이, 브로콜리 추출물과 콜라비 새싹 추출물은 1: 0.5 ~ 1: 0.8의 중량비로 첨가되는 것이 바람직하고, 더욱 바람직하게는 상기 브로콜리 추출물과 콜라비 새싹 추출물은 1: 0.61의 중량비로 첨가되는 것이 좋다.As such, the broccoli extract and the kohlrabi sprout extract is preferably added in a weight ratio of 1: 0.5 to 1: 0.8, and more preferably the broccoli extract and the kohlrabi sprout extract are added in a weight ratio of 1: 0.61. .
이상에서, 본 발명의 실시 예를 구성하는 모든 구성 요소들이 하나로 결합하거나 결합하여 동작하는 것으로 설명되었다고 해서, 본 발명이 반드시 이러한 실시 예에 한정되는 것은 아니다. 즉, 본 발명의 목적 범위 안에서라면, 그 모든 구성 요소들이 하나 이상으로 선택적으로 결합하여 동작할 수도 있다. 또한, 이상에서 기재된 '포함하다', '구성하다' 또는 '가지다' 등의 용어는, 특별히 반대되는 기재가 없는 한, 해당 구성 요소가 내재할 수 있음을 의미하는 것이므로, 다른 구성 요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것으로 해석되어야 한다. 기술적이거나 과학적인 용어를 포함한 모든 용어들은, 다르게 정의되지 않는 한, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미가 있다. 사전에 정의된 용어와 같이 일반적으로 사용되는 용어들은 관련 기술의 문맥상의 의미와 일치하는 것으로 해석되어야 하며, 본 발명에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다. In the above description, all elements constituting the embodiments of the present invention are described as being combined or operating in combination, but the present invention is not necessarily limited to the embodiments. In other words, within the scope of the present invention, all of the components may be selectively operated in combination with one or more. In addition, the terms such as 'comprise', 'comprise' or 'having' described above mean that a corresponding component may be included unless specifically stated otherwise, and thus, other components are excluded. It should be construed that it may further include other components instead. All terms, including technical and scientific terms, have the same meaning as commonly understood by one of ordinary skill in the art unless otherwise defined. Terms used generally, such as terms defined in a dictionary, should be interpreted to coincide with the contextual meaning of the related art, and shall not be interpreted in an ideal or excessively formal sense unless explicitly defined in the present invention.
이상의 설명은 본 발명의 기술 사상을 예시적으로 설명한 것에 불과한 것으로서, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자라면 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 다양한 수정 및 변형이 가능할 것이다. 따라서, 본 발명에 개시된 실시 예들은 본 발명의 기술 사상을 한정하기 위한 것이 아니라 설명하기 위한 것이고, 이러한 실시 예에 의하여 본 발명의 기술 사상의 범위가 한정되는 것은 아니다. 본 발명의 보호 범위는 아래의 청구범위에 의하여 해석되어야 하며, 그와 동등한 범위 내에 있는 모든 기술 사상은 본 발명의 권리범위에 포함되는 것으로 해석되어야 할 것이다.The above description is merely illustrative of the technical idea of the present invention, and those skilled in the art to which the present invention pertains may make various modifications and changes without departing from the essential characteristics of the present invention. Therefore, the embodiments disclosed in the present invention are not intended to limit the technical idea of the present invention but to describe the present invention, and the scope of the technical idea of the present invention is not limited by these embodiments. The protection scope of the present invention should be interpreted by the following claims, and all technical ideas within the equivalent scope should be interpreted as being included in the scope of the present invention.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170165200A KR102013871B1 (en) | 2017-12-04 | 2017-12-04 | Composition for improving hair growth |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170165200A KR102013871B1 (en) | 2017-12-04 | 2017-12-04 | Composition for improving hair growth |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190065734A KR20190065734A (en) | 2019-06-12 |
KR102013871B1 true KR102013871B1 (en) | 2019-08-23 |
Family
ID=66846075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170165200A KR102013871B1 (en) | 2017-12-04 | 2017-12-04 | Composition for improving hair growth |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102013871B1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101757469B1 (en) * | 2015-09-23 | 2017-07-12 | (주)애니닥터헬스케어 | Compositions for promoting hair growth and inhibiting inflammation comprising mixed extracts of natural products |
KR101757908B1 (en) * | 2015-10-13 | 2017-07-14 | 에인에이 (주) | Photosensitive hair growth promoting composition for hair growth promotion with excellent light absorption property |
-
2017
- 2017-12-04 KR KR1020170165200A patent/KR102013871B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20190065734A (en) | 2019-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101530490B1 (en) | External use composition containing herb extract for hair growth | |
KR20110086894A (en) | Cosmetic included to alkaline powder & solution of shell | |
KR101387308B1 (en) | Skin whitening composition by using of dendropanax morbifera ferment extract | |
JP2010501551A (en) | Use of rare earth elements for hair improvement | |
US20160287511A1 (en) | Formulation for Treatment of Hairs | |
CN113171329A (en) | Plant multi-effect anti-hair loss hair-growing hair-nourishing compound composition and preparation method thereof | |
WO2005034894A1 (en) | Hair growth stimulant composition | |
KR20160054087A (en) | The composition of Caffeoylpentapeptide Cosmetic that has the Constitution of skin Anti-irritant for the Prevention of Hair Loss and the Promotion of Hair Growth | |
JP2008143784A (en) | Cell growth promoter | |
JP3223404B2 (en) | Hair restorer | |
KR101757469B1 (en) | Compositions for promoting hair growth and inhibiting inflammation comprising mixed extracts of natural products | |
KR100970126B1 (en) | Method of preparing?compositions for preventing depilation and for promoting hair-growing | |
KR102606356B1 (en) | Cosmetic composition for regenerating skin and improving skin wrinkle | |
KR101547758B1 (en) | Composition for preventing hair loss and promoting hair growth | |
KR20170133721A (en) | A composition comprising extract of inula japonica thunberg, epimedium koreanum and knotgrass as active ingrediant for functional cosmetics | |
KR101798632B1 (en) | Cosmetic composition containing stellera chamaejasme extract or fraction thereof and use thereof | |
KR101476004B1 (en) | Cosmetic composition containing onion skin extracts and loquat leaf extracts for the acceleration of hair growth | |
KR20190010814A (en) | Composition for hair growth | |
KR20110001290A (en) | Pharmaceutical composition for preventing the hair from falling out | |
JP2014185131A (en) | Hair growing agent and hair cosmetic for hair growth | |
KR102013871B1 (en) | Composition for improving hair growth | |
CN106333916B (en) | Scalp nourishing liquid for treating alopecia and promoting hair growth | |
AU2021275500B2 (en) | Protein hydrolysate of Moringa Peregrina Seed Cake for Its Application as a Medicament, Process for Obtaining Same and Pharmaceutical and Dermatological Compositions | |
CN111939191B (en) | Composition for promoting angiogenesis around hair follicle and/or promoting hair growth and application | |
KR20210083236A (en) | Composition for preventing hair loss and improving the scalp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |